InspireMD Inc (NSPR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 6.45 is considered Undervalued compared with the five-year average of -2.02. The fair price of InspireMD Inc (NSPR) is between 3.03 to 4.72 according to relative valuation method. Compared to the current price of 1.83 USD , InspireMD Inc By Undervalued By 39.6%.

Relative Value

Fair Zone

3.03-4.72

Current Price：1.83

39.6%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is InspireMD Inc (NSPR) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

InspireMD Inc (NSPR) has a current Price-to-Book (P/B) ratio of 1.22. Compared to its 3-year average P/B ratio of 1.72, the current P/B ratio is approximately -29.20% higher. Relative to its 5-year average P/B ratio of 1.34, the current P/B ratio is about -9.02% higher. InspireMD Inc (NSPR) has a Forward Free Cash Flow (FCF) yield of approximately -43.25%. Compared to its 3-year average FCF yield of -40.76%, the current FCF yield is approximately 6.11% lower. Relative to its 5-year average FCF yield of -55.88%, the current FCF yield is about -22.60% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NSPR competitors is 38.10, providing a benchmark for relative valuation. InspireMD Inc Corp (NSPR.O) exhibits a P/S ratio of 6.45, which is -83.06% above the industry average. Given its robust revenue growth of 39.39%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NSPR increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NSPR in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NSPR currently overvalued or undervalued?

What is InspireMD Inc (NSPR) fair value?

NSPR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of InspireMD Inc (NSPR) is between 3.03 to 4.72 according to relative valuation method.

How does NSPR's valuation metrics compare to the industry average?

The average P/S ratio for NSPR's competitors is 38.10, providing a benchmark for relative valuation. InspireMD Inc Corp (NSPR) exhibits a P/S ratio of 6.45, which is -83.06% above the industry average. Given its robust revenue growth of 39.39%, this premium appears sustainable.

What is the current P/B ratio for InspireMD Inc (NSPR) as of Mar 03 2026?

As of Mar 03 2026, InspireMD Inc (NSPR) has a P/B ratio of 1.22. This indicates that the market values NSPR at 1.22 times its book value.

What is the current FCF Yield for InspireMD Inc (NSPR) as of Mar 03 2026?

As of Mar 03 2026, InspireMD Inc (NSPR) has a FCF Yield of -43.25%. This means that for every dollar of InspireMD Inc's market capitalization, the company generates -43.25 cents in free cash flow.

What is the current Forward P/E ratio for InspireMD Inc (NSPR) as of Mar 03 2026?

As of Mar 03 2026, InspireMD Inc (NSPR) has a Forward P/E ratio of -2.30. This means the market is willing to pay $-2.30 for every dollar of InspireMD Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for InspireMD Inc (NSPR) as of Mar 03 2026?

As of Mar 03 2026, InspireMD Inc (NSPR) has a Forward P/S ratio of 6.45. This means the market is valuing NSPR at $6.45 for every dollar of expected revenue over the next 12 months.

NSPR Valuation